Literature DB >> 19136031

Immune involvement in schizophrenia and autism: etiology, pathology and animal models.

Paul H Patterson1.   

Abstract

There is increasing evidence of immune involvement in both schizophrenia and autism. Of particular interest are striking abnormalities in the expression of immune-related molecules such as cytokines in the brain and cerebral spinal fluid (CSF). It is proposed that this represents a permanent state of brain immune dysregulation, which begins during early development. One possibility is that maternal infection, a known risk factor for schizophrenia and autism, sets this immune activation in motion. Several animal models are being used to investigate this hypothesis. There is also recent evidence that, among schizophrenic subjects, those associated with maternal infection display a distinctive pathology, which suggests that diverse causes for this disorder may explain some of its heterogeneity. The human and animal results related to immune involvement suggest novel therapeutic avenues based on immune interventions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19136031     DOI: 10.1016/j.bbr.2008.12.016

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  308 in total

1.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

2.  Activation of neonatal microglia can be influenced by other neural cells.

Authors:  Alexandra Turano; Jennifer H Lawrence; Jaclyn M Schwarz
Journal:  Neurosci Lett       Date:  2017-07-31       Impact factor: 3.046

Review 3.  Advances in nonhuman primate models of autism: Integrating neuroscience and behavior.

Authors:  M D Bauman; C M Schumann
Journal:  Exp Neurol       Date:  2017-08-01       Impact factor: 5.330

Review 4.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

5.  Association between parental hospital-treated infection and the risk of schizophrenia in adolescence and early adulthood.

Authors:  Philip R Nielsen; Thomas M Laursen; Preben B Mortensen
Journal:  Schizophr Bull       Date:  2011-10-20       Impact factor: 9.306

Review 6.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

7.  Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice.

Authors:  D Ehninger; Y Sano; P J de Vries; K Dies; D Franz; D H Geschwind; M Kaur; Y-S Lee; W Li; J K Lowe; J A Nakagawa; M Sahin; K Smith; V Whittemore; A J Silva
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

Review 8.  Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders.

Authors:  Mustafa Sahin; Mriganka Sur
Journal:  Science       Date:  2015-10-15       Impact factor: 47.728

Review 9.  Studying longitudinal trajectories in animal models of psychiatric illness and their translation to the human condition.

Authors:  Carlos A Driscoll; Christina S Barr
Journal:  Neurosci Res       Date:  2015-08-12       Impact factor: 3.304

10.  Alteration of adaptive behaviors of progeny after maternal mobile phone exposure.

Authors:  Nicolas Petitdant; Anthony Lecomte; Franck Robidel; Christelle Gamez; Kelly Blazy; Anne-Sophie Villégier
Journal:  Environ Sci Pollut Res Int       Date:  2018-02-03       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.